Retinopathy of Prematurity - Epidemiology Forecast- 2036

Retinopathy of Prematurity (ROP) Insights and Trends

• Among the 7MM, the United States accounted for the highest number of incident cases of Retinopathy of Prematurity, accounting for approximately 18,200 cases in 2025. These cases are projected to increase during the forecast period of 2026-2036.
• The risk factor for developing Retinopathy of Prematurity (ROP) is the baby's age and weight at birth. Especially children with gestational age at birth below 31 weeks or a birth weight of less than 1,500 g are in danger of developing Retinopathy of Prematurity.
• In France, approximately 30% of preterm infants by birth weight (<=1,500g) develop Retinopathy of Prematurity.
• Advancements in life-preserving technologies have led to increased survival of premature and low birth weight (LBW) babies. As estimated, gestational age (EGA) and LBW are well-known to be inversely related to Retinopathy of Prematurity risk; these developments in neonatal care have increased the population of babies at risk for Retinopathy of Prematurity.
• The studies examining the incidence of Retinopathy of Prematurity have focused on various groups of premature infants, leading to variations in the calculated ROP incidence rates. This is due to differences in the worldwide screening guidelines, ranging from infants born before 30 to 37 weeks of gestational age (GA) and weighing between 1,000 g and 2,500 g. These divergent criteria make it challenging to compare ROP incidence rates across different studies directly.
• Approximately 9% of the total incident cases of ROP in the US went for initial treatment, out of which 36% of cases required retreatment. Approximately 30% of patients require treatment for Retinopathy of Prematurity in Japan.

Retinopathy of Prematurity (ROP) Epidemiology Forecast in the 7MM

• 2025 Incident Cases of ROP: ~35,700
• ROP Growth Rate (2026-2036): 1% CAGR

DelveInsight's 'Retinopathy of Prematurity (ROP) - Epidemiology Forecast - 2036' report delivers an in-depth understanding of the ROP, historical and forecasted epidemiology in the United States, EU4 (Germany, Spain, Italy, and France) and the United Kingdom, and Japan.

Retinopathy of Prematurity (ROP) Understanding and Diagnosis Algorithm

Retinopathy of Prematurity (ROP) Overview

ROP is an eye disease that can happen in premature babies (born early) or who weigh less than 1,500 g at birth. Retinopathy of Prematurity happens when abnormal blood vessels grow in the retina (the light-sensitive layer of tissue in the back of your eye). Some babies with Retinopathy of Prematurity have mild cases and get better without treatment. However, some babies need treatment to protect their vision and prevent blindness.

Retinopathy of Prematurity (ROP) Diagnosis

ROP is diagnosed through a comprehensive eye exam by a specialized ophthalmologist. This exam involves dilating the infant's pupils to assess the retina's blood vessels. The disease is categorized into stages based on severity, location, and extent of abnormal vessel growth. Retinal imaging may aid in monitoring.

Retinopathy of Prematurity (ROP) Epidemiology

Key Findings from ROP Epidemiological Analysis and Forecast

• According to DelveInsight's estimates, the total number of incident cases of preterm infants by birth weight (<=1,500 g) in the 7MM was ~94,500 in 2025. As per the estimate, the incidence of preterm infants by birth weight (<=1,500 g) in the 7MM is anticipated to increase during the forecast period of 2026-2036.
• Among the 7MM, the United States has the highest number of patients undergoing treatment for ROP, followed by Japan, while Spain has the lowest in 2025.
• In Japan, the treatment rate is 30%, while the retreatment rate stands at 17% in 2025.

Scope of the Report:

• The report covers a segment of an executive summary, a descriptive overview of ROP, explaining its causes, signs, and symptoms, and pathogenesis.
• Comprehensive insight has been provided into the epidemiology segments and forecasts, the future growth potential of the diagnosis rate, and disease progression.

Report Insights

ROP patient population forecast

Report Key Strengths

• Epidemiology-based (epi-based) bottom-up forecasting
• 11-year forecast
• Patient burden trends (by geography)

FAQs:

• What are the disease risks, burdens, and unmet needs of ROP? What will be the growth opportunities across the 7MM concerning the patient population with ROP?
• What is the historical and forecasted ROP patient pool in the US, EU4 (Germany, France, Italy, and Spain), the UK, and Japan?

Reasons to Buy:

• Insights on patient burden/disease prevalence, evolution in diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
• To understand key opinion leaders' perspectives on the diagnostic challenges to overcome barriers in the future.
• Detailed insights into various factors hampering disease diagnosis and other existing diagnostic challenges.